ICU Medical (ICUI) Tops Q4 EPS by 4c; Offers FY23 EPS Guidance

ICU Medical (NASDAQ: ICUI) reported Q4 EPS of $1.60, $0.04 better than the analyst estimate of $1.56. Revenue for the quarter came in at $578 million versus the consensus estimate of $578.77 million.

GUIDANCE:

ICU Medical sees FY2023 EPS of $5.75-$7.25, versus the consensus of $7.22.

For earnings history and earnings-related data on ICU Medical (ICUI) click here.

You May Also Be Interested In

• Rent the Runway (RENT) Reports Q2 Loss of $0.38/sh
• Navan, Inc. (NAVN) Tops Q2 EPS by 1c, Offers Guidance
• Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance